Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EmergingMed operates a digital platform and Clinical Trial Navigation Service, supporting sponsors and patients in the clinical trial enrollment process, especially for cancer trials. The company does not develop its own therapeutics but optimizes trial recruitment and retention for clinical studies, partnering with sites, sponsors, and advocacy groups to improve patient access and enrollment metrics. Its services have guided over 115,000 patients in finding cancer clinical trials and maintain one of the largest curated cancer trial databases in the U.S.[5][1][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EmergingMed.